Rezolute Form 4 shows new director RSUs and stock options

Rhea-AI Filing Summary

Rezolute, Inc. (RZLT) reported a new equity compensation grant to one of its directors. On 11/19/2025, the reporting person acquired 21,000 common shares as a grant of restricted stock units at a price of $0, reflecting stock-based compensation rather than a purchase. After this transaction, the director beneficially owned 21,000 common shares directly.

On the same date, the director also received a stock option to buy 12,000 common shares at an exercise price of $10.16 per share, with the option expiring on 11/19/2035. Both the 21,000 restricted stock units and the 12,000 options are scheduled to fully vest on December 1, 2026, tying the director’s compensation to Rezolute’s future share performance.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Harris Erik

(Last) (First) (Middle)

C/O REZOLUTE, INC.

275 SHORELINE DRIVE, SUITE 500

(Street)

REDWOOD CITY CA 94065

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Rezolute, Inc. [ RZLT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	11/19/2025		A		21,000(1)	A	$0	21,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Director Stock Option (Right to Buy)	$10.16	11/19/2025		A		12,000		(2)	11/19/2035	Common Shares	12,000	$0	12,000	D

Explanation of Responses:

1. Represents grant of restricted stock units which fully vest on December 1, 2026.

2. The options fully vest on December 1, 2026.

	/s/ Erik Harris	11/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Rezolute (RZLT) report on this Form 4?

The filing reports that a Rezolute director received 21,000 restricted stock units and a stock option for 12,000 common shares as equity compensation on 11/19/2025.

What is the exercise price and term of the new Rezolute (RZLT) stock options?

The director received a stock option to buy 12,000 common shares at an exercise price of $10.16 per share, with an expiration date of 11/19/2035.

How many Rezolute (RZLT) shares did the director own after the RSU grant?

Following the reported transaction, the director beneficially owned 21,000 common shares of Rezolute directly.

When do the Rezolute (RZLT) restricted stock units vest?

The 21,000 restricted stock units granted to the director are scheduled to fully vest on December 1, 2026, according to the explanation of responses.

When do the Rezolute (RZLT) stock options vest for this director grant?

The filing states that the 12,000 stock options fully vest on December 1, 2026, aligning with the vesting date of the restricted stock units.

Was the Rezolute (RZLT) Form 4 filed for a single reporting person?

Yes. The Form 4 indicates it was filed by one reporting person, who serves as a director of Rezolute.